| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | US7479278 Troponin I polypeptide fragments and uses thereof |
| 01/20/2009 | US7479277 Method for reducing intraocular pressure using integrin-linked kinase inhibitor |
| 01/20/2009 | US7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/20/2009 | US7479275 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 01/20/2009 | US7479274 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
| 01/20/2009 | US7479273 Method of administering and using VEGF inhibitors for the treatment of renal cell cancer |
| 01/20/2009 | US7479272 Method of administering and using VEGF inhibitors for the treatment of breast cancer |
| 01/20/2009 | US7479271 Appetite hormone specific immunoglobulin for prevention and treatment of eating and weight related disorders |
| 01/20/2009 | US7479266 Polyvalent conjugate vaccine for cancer |
| 01/20/2009 | CA2305621C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 01/20/2009 | CA2279935C Chelating immunostimulating complexes |
| 01/20/2009 | CA2247103C Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
| 01/15/2009 | WO2009009800A2 Antitoxin destabilization technology |
| 01/15/2009 | WO2009009739A2 Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer |
| 01/15/2009 | WO2009009712A1 Polymeric drug delivery system containing a multi-substituted aromatic moiety |
| 01/15/2009 | WO2009009670A2 Apparatus and method for harvesting biologics from eggs |
| 01/15/2009 | WO2009009591A2 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 01/15/2009 | WO2009009430A1 Diagnosing and protecting horses against papillomavirus |
| 01/15/2009 | WO2009009407A1 Antibody formulations |
| 01/15/2009 | WO2009009116A2 Combination therapies employing gitr binding molecules |
| 01/15/2009 | WO2009009114A2 Compositions and methods for treating and diagnosing cancer |
| 01/15/2009 | WO2009009063A1 Immunotherapy for hematological malignancies |
| 01/15/2009 | WO2009009054A1 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 01/15/2009 | WO2009009034A2 Methods and compositions useful in the treatment of mucositis |
| 01/15/2009 | WO2009008928A2 Methods for treating nervous system injury and disease |
| 01/15/2009 | WO2009008573A1 An avian influenza virus vaccine and a method for preparing same |
| 01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
| 01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |
| 01/15/2009 | WO2009008489A1 Antibody liposome |
| 01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
| 01/15/2009 | WO2009008176A1 Therapeutic agent for lymphoma |
| 01/15/2009 | WO2009007336A1 Methods for generating an immune response using dna and a viral vector |
| 01/15/2009 | WO2009007298A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 01/15/2009 | WO2009007272A1 Novel formulation |
| 01/15/2009 | WO2009007244A2 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/15/2009 | WO2009007222A1 An antibody specific for the tn antigen for the treatment of cancer |
| 01/15/2009 | WO2009006700A1 Immunology treatment for biofilms |
| 01/15/2009 | WO2009006688A1 Regulating il-4 and il- 13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
| 01/15/2009 | WO2009006680A1 Epitopes of herpes simplex virus |
| 01/15/2009 | WO2008127094A3 New virulence factors of streptococcus pnuemoniae |
| 01/15/2009 | WO2008110885A3 Methods of treating ophthalmic diseases |
| 01/15/2009 | WO2008109667A9 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 01/15/2009 | WO2008103318A3 The adipocyte secreted protein ccdc80 is a potent stimulator of bone formation |
| 01/15/2009 | WO2008102136A3 Solid pharmaceutical and vaccine dose |
| 01/15/2009 | WO2008100624A3 Antibodies against erbb3 and uses thereof |
| 01/15/2009 | WO2008100508A3 Puumala virus full-length m segment-based dna vaccines |
| 01/15/2009 | WO2008090223A3 Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| 01/15/2009 | WO2008074867A3 Anti-fc-receptor single domain antibodies (nanobodies-tm) and therapeutic use |
| 01/15/2009 | WO2008073160A3 Methods for converting or inducing protective immunity |
| 01/15/2009 | WO2008021408A3 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 01/15/2009 | WO2007092419A3 Method for non-invasive detection and treatment of cerebral aneurysms |
| 01/15/2009 | WO2007070501A3 A vaccination method |
| 01/15/2009 | WO2007053487A3 Methods and devices for detection of the strain of a pathogen |
| 01/15/2009 | WO2007001459A8 Compositions and methods for modulating lymphocyte activity |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018080 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017538 For modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein |
| 01/15/2009 | US20090017536 Modified vaccinia ankara virus variant and cultivation method |
| 01/15/2009 | US20090017532 Vector |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017076 Treatment for cd5+ b cell lymphoma |
| 01/15/2009 | US20090017075 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 01/15/2009 | US20090017074 Culture medium for haemophilus influenzae type b |
| 01/15/2009 | US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| 01/15/2009 | US20090017072 Pneumococcal capsular saccharides complex vaccine; for infants |
| 01/15/2009 | US20090017071 Methods for treating neurogenic inflammation |
| 01/15/2009 | US20090017070 In vitro model for hepatitis c virion production |
| 01/15/2009 | US20090017069 SARS Vaccine Compositions and Methods of Making and Using Them |
| 01/15/2009 | US20090017068 Vaccines against West Nile Virus |
| 01/15/2009 | US20090017067 Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase |
| 01/15/2009 | US20090017066 Novel vlps derived from cells that do not express a viral matrix or core protein |
| 01/15/2009 | US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 01/15/2009 | US20090017064 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 01/15/2009 | US20090017063 Edible vaccine |
| 01/15/2009 | US20090017062 Using variation in NADPH oxidase activity as evaluative tool in identifying modulators which enhance parvovirus transduction |
| 01/15/2009 | US20090017061 Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan |
| 01/15/2009 | US20090017060 Cleavable Vaccine Compositions and Uses Thereof and Methods of Making and Using the Same |
| 01/15/2009 | US20090017059 Complex of serotype to bacteria toxin such as tetanus, diphtheria, pertussis, cytolysin |
| 01/15/2009 | US20090017057 Stimulation of an immune response by cationic lipids |
| 01/15/2009 | US20090017056 Skin immunization using lt-sta fusion proteins |
| 01/15/2009 | US20090017055 immunogenic composition comprising an isolated polypeptide effective for inducing an immune response to liver stage Plasmodium falciparum in a mammalian subject, and a pharmaceutically acceptable carrier; use in the prevention, diagnosis, and treatment of malaria |
| 01/15/2009 | US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/15/2009 | US20090017053 Composition and Method for Preventing or Treating a Virus Infection |
| 01/15/2009 | US20090017052 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 01/15/2009 | US20090017051 Allergy vaccines and their preparation |
| 01/15/2009 | US20090017050 Egfr antigen-binding molecules and uses thereof |
| 01/15/2009 | US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017047 Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders |
| 01/15/2009 | US20090017046 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 01/15/2009 | US20090017045 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue |
| 01/15/2009 | US20090017044 Antibodies to the Human Prolactin Receptor |